No. Even small amounts of alcohol can trigger a disulfiram-ethanol reaction, which may be severe and potentially life-threatening. Complete abstinence from all ethanol-containing products is required throughout treatment and for up to two weeks after the last dose.
The inhibition of aldehyde dehydrogenase can persist for 1-2 weeks after the final tablet, so alcohol should be avoided during this wash-out period.
Seek immediate medical attention. Symptoms can include rapid heartbeat, low blood pressure, vomiting, and severe flushing. Prompt treatment can prevent complications.
Yes. Certain sauces, vinegars, desserts, and fermented foods may contain ethanol. It is advisable to read ingredient labels and avoid products that list “alcohol,” “ethanol,” or “wine” as components.
Disulfiram can interact with some antidepressants metabolized by CYP2E1, potentially altering their levels. Always inform the prescriber of all current medications, including psychiatric drugs, so dose adjustments can be evaluated.
It is contraindicated in patients with acute hepatitis or severe liver impairment. Those with mild to moderate liver disease may be prescribed Antabuse only after careful assessment and regular liver function monitoring.
Symptoms may include swelling of the face, lips, tongue, or throat, difficulty breathing, and widespread rash or hives. Seek emergency care if any of these occur.
No. Disulfiram is not approved for smoking cessation and does not address nicotine dependence. Other evidence-based pharmacotherapies (e.g., varenicline, nicotine replacement) are recommended for that purpose.
Antabuse creates a physiological deterrent through enzyme inhibition, whereas other agents (e.g., naltrexone, acamprosate) act on craving pathways or neurotransmitter balance. Choice of therapy depends on patient preferences, medical history, and treatment goals.
A baseline liver function panel is standard to ensure the liver can safely metabolize the drug. Additional tests may be ordered based on individual health status.
Antabuse is a prescription medication whose active ingredient is disulfiram. It belongs to the addiction & quit-smoking therapeutic class and is supplied in pill form. In the United Kingdom, Antibuse is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and is available only with a prescription.
The medication is marketed in two strengths: 250 mg and 500 mg tablets. It is specifically indicated to support individuals who have decided to stop drinking alcohol by producing an unpleasant reaction when alcohol is consumed.
Disulfiram interferes with the normal metabolism of ethanol. After alcohol is ingested, the body normally converts it to acetaldehyde (a toxic intermediate) and then quickly to acetate via the enzyme aldehyde dehydrogenase (ALDH). Disulfiram blocks ALDH, causing acetaldehyde to accumulate.
By creating a strong deterrent to drinking, disulfiram helps motivated individuals maintain abstinence.
Antabuse is approved in the UK for the following indication:
The medication is not indicated for smoking cessation, despite the broader category label. Its use is limited to adult patients (≥18 years) under close medical supervision.
Current peer-reviewed evidence does not support routine off-label use of disulfiram for conditions other than alcohol dependence. Some small studies have explored its role in cocaine dependence, but these remain investigational and are not endorsed by regulatory agencies. Off-label use would require individualized risk assessment and specialist supervision.
Special Populations
These effects are usually mild and may diminish with continued therapy. If they persist or worsen, a healthcare professional should be consulted.
Patients should provide a complete medication list-including over-the-counter products and herbal supplements-to their prescriber.
Dosing must be individualized based on liver function, concomitant medications, and patient tolerance. The prescriber determines the appropriate regimen.
This article provides educational information about Antabuse (disulfiram) and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
